In this episode of SurgOnc Today®, Dr. Melanie Ongchin from the University of Pittsburgh, Dr. Trang Nguyen from Washington University, and Dr. Molly Kledzik from WVU are joined by Ms. Lindsay Barad, a patient and advocate for PMP Pals. Diagnosed with LAMN with PMP, Lindsay shares her unique perspective on the patient experience following CRS/HIPEC, emphasizing the challenges and considerations of young female patients regarding fertility.

This episode of SurgOnc Today is episode 3 of our Management of ALT/WDLPS series. Dr. Brian Kadera, Dr. Jessica Cintolo-Gonzalez and Dr. John Miura will discuss surveillance and treatment approaches for recurrent well-differentiated liposarcoma (WDLPS) in the retroperitoneum, which has a very high rate of recurrence. Even after radical resections by experienced surgeons, these tumors can recur a decade later. They will review the natural history of late-stage WDLPS, the actual risk of transformation from well-differentiated to dedifferentiated liposarcoma (WD to DD), and a multidisciplinary treatment approach to unresectable recurrences.

In this episode of SurgOnc Today®, we talk with Dawn Mussallem, DO, a certified lifestyle medicine physician. She helps us walk through the importance of staying healthy and provides thoughts and suggestions for healthy living. We discuss exercise, nutrition, health and happiness.

On this episode of SurgOnc Today®, in honor of Asian American Native Hawaiian Pacific Islander (AANHPI) month, we highlight the achievements and contributions of those with AANHPI background and their involvement in surgical oncology care. Today we speak with some of the AANHPI leaders in surgical oncology around the US, providing insight into how their upbringing/heritage affected their careers in medicine.

Moderators: Tammy Ju

Faculty: Vikas Dudeja, Anai Kothari

In this episode of SurgOnc Today, Alexander Parikh, MD, MPH, from the University of Texas – San Antonio and Chair of the SSO HPB disease site working group, and Laleh G. Melstrom, MD, MSCI, from City of Hope National Medical Center, are joined by Timothy Newhook, MD, from the University of Texas MD Anderson Cancer Center and Andreas Kaiser, MD, from the City of Hope. We will be discussing the management of synchronous rectal cancer with liver metastases.

In this episode of SurgOnc Today, Brian Sparkman, MD, is joined by Lily Lai, MD, Margo Shoup, MD, MBA, and Kristen Massimino, MD, to discuss how CGSO fellowships prepare surgeons for a career in community practice and how we might improve this in the future.

Show Notes:

Medical students are caught in the residency 'research arms race' - STAT - https://www.statnews.com/2024/04/29/research-arms-race-medical-students-residency-applications/

Behrens S, Ann Surg Oncol. 2024 Jan; 31(1):31-42. DOI: 10.1245/s10434-023-14524-x

Clarke CN. Surg Oncol Clin N Am. 2022 Jan; 31910: 21 – 27. DOI: 10.1016/j.soc.2021.07.004

Wach MW. Ann Surg Oncol. 2019 Sep; 26(9):2675-2681. DOI: 10.1245/s10434-019-07372-1

In this episode of SurgOnc Today, live from SSO 2024, Dr. Alex Parikh from the University of Texas – San Antonio and Chair of the SSO HPB disease site working group, and Dr. Julie Hallet from the University of Toronto, and Vice-Chair of the SSO HPB disease site working group, are joined by Dr. Ana Gleisner from the University of Colorado and Dr. Skye Mayo from the Oregon Health and Sciences University. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: determining resectability as it relates to vascular involvement, and the role of neoadjuvant therapy.

In this episode of SurgOnc Today®, Sonia Orcutt, MD and Michail Mavros, MD, from the University of Arkansas for Medical Sciences are joined by Callisia N. Clarke, MD, MS, FACS, FSSO, Chief of the Division of Surgical Oncology at the Medical College of Wisconsin, and Alexandra Gangi, MD, FSSO, Director of the Gastrointestinal Tumor Program at Cedars Sinai Medical Center. The optimal treatment of high-grade well-differentiated neuroendocrine tumors has not been well-described, as they have only in recent years been identified as distinct from neuroendocrine carcinomas. The panelists discuss the most up-to-date information on diagnosis and management of gastroenteropancreatic high-grade well differentiated neuroendocrine tumors.

In this episode of SurgOnc Today®, Jennifer Plichta MD, Associate Professor of Surgery and Director of the Breast Risk Assessment Clinic at the Duke University Medical Center, is joined by Melissa Pilewskie, MD, Associate Professor of Surgery and Director of the Breast Care Center at the University of Michigan and Zahraa AlHilli, MD, MBA, Interim Director of the Breast Center and Co-Director of the Comprehensive Breast Program at Cleveland Clinic. Given the continuous advancements in breast imaging and risk assessment, it is important to be familiar with the latest imaging modalities, the risk assessment tools available, and how to incorporate them into routine clinical care. This episode focuses on the practical considerations for managing patients with an increased risk of breast cancer.

In this episode of SurgOnc Today ®, Alex Parikh, MD, MPH, FACS, FSSO, from the University of Texas – San Antonio and Julie Hallet, MD, M.Sc., FRCSC, FSSO from the University of Toronto are joined by Monica M. Dua, MD, from Stanford University and Ching-Wei Tzeng, , MD, FACS, FSSO, from the MD Anderson Cancer Center. They will be discussing two important aspects of the surgical management of perihilar cholangiocarcinoma: strategies for pre-operative optimization and biliary drainage, and management of the future liver remnant. This is part one of a two-part series.